Status:

TERMINATED

Response of the Autonomic Nervous System to Auricular Stimulation of the Vagus Nerve (x)

Lead Sponsor:

Hôpital Européen Marseille

Collaborating Sponsors:

Aix Marseille Université

Conditions:

Vasoconstriction Disorder of Extremities

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

While invasive vagal stimulation has proven its therapeutic effectiveness over the past 20 years, particularly in the treatment of epilepsy or depression, its implementation is hampered by the high co...

Detailed Description

Main objective: to measure the physiological impact of two auricular stimuli on the same innervation territory but with opposite actions according to traditional therapies. An identical physiological...

Eligibility Criteria

Inclusion

  • Healthy volunteers, male and female, aged 18 to 60 years
  • BMI (Body mass index) \<=30
  • Not participating in another clinical study with an investigational product

Exclusion

  • Drug treatment for cardiological, neurological or anticoagulant purposes
  • History of diabetes, known neuropathy, high blood pressure, heart rhythm disorders, syncope or palpitation
  • Known cryoglobulinemia
  • Subject with Raynaud's syndrome
  • Intra-auricular device of the piercing type,
  • Psychoactive substance use, excessive alcohol consumption (\>2 units per day chronically or \>6 units per day recreationally) and tobacco (\>5 cigarettes per day)
  • Subject unable to read French
  • Subject covered by Articles L1121-5 to 1121-8 of the Public Health Code, namely:
  • Pregnant, postpartum and breastfeeding women
  • Persons deprived of their liberty by a judicial or administrative decision
  • Persons undergoing psychiatric care under Articles L3112-1 and L3113-1 who are not covered by the provisions of Article L1121-8
  • Minors
  • Persons of full age who are subject to a legal protection measure or who are unable to express their consent

Key Trial Info

Start Date :

January 17 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 21 2019

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04130893

Start Date

January 17 2019

End Date

November 21 2019

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Européen Marseille

Marseille, PACA, France, 13003